English
Insider transactions
EDGARMILESTONE PHARMACEUTICALS INC.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-20.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 13 transactions, 523,079 shares
- Sum of shares × price per share: 1,176,157.46
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–50 of 56
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-10 Filed 2026-06-12 | Saik Andrew Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 77,000 | 0 | — | 77,000 | Direct (D) | No | F1
| Open filing 0001616284-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-10 Filed 2026-06-12 | Giles Lisa M. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 77,000 | 0 | — | 77,000 | Direct (D) | No | F1
| Open filing 0001568850-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-10 Filed 2026-06-12 | PAPA JOSEPH C Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 77,000 | 0 | — | 77,000 | Direct (D) | No | F1
| Open filing 0001242215-26-000014 Read from the filing’s XML Dispute this row |
| 2026-06-10 Filed 2026-06-12 | Duty Stuart Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 77,000 | 0 | — | 77,000 | Direct (D) | No | F1
| Open filing 0001970274-26-000004 Read from the filing’s XML Dispute this row |
| 2026-06-10 Filed 2026-06-12 | Fischer Seth H. Z. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 77,000 | 0 | — | 77,000 | Direct (D) | No | F1
| Open filing 0001573553-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-10 Filed 2026-06-12 | TOMSICEK MICHAEL JOHN Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 77,000 | 0 | — | 77,000 | Direct (D) | No | F1
| Open filing 0001570392-26-000003 Read from the filing’s XML Dispute this row |
| 2026-06-10 Filed 2026-06-12 | Wills Robert James Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 77,000 | 0 | — | 77,000 | Direct (D) | No | F1
| Open filing 0001634189-26-000002 Read from the filing’s XML Dispute this row |
| 2026-04-16 Filed 2026-04-20 | Oliveto Joseph Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 36,500 | 2.26 | 82,490Derived: shares × price per share. Exact value 82490.00. | 446,244 | Direct (D) | Yes | F1, F2
| Open filing 0001437782-26-000010 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-05 | Nelson Jeffrey Edward Officer: Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 204,000 | 0 | — | 204,000 | Direct (D) | No | F1, F2
| Open filing 0001943112-26-000005 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-05 | Muller Lorenz Officer: Chief Commercial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 204,000 | 0 | — | 204,000 | Direct (D) | No | F1, F2
| Open filing 0001771207-26-000005 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-05 | Bharucha David Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 204,000 | 0 | — | 204,000 | Direct (D) | No | F1, F2
| Open filing 0001910985-26-000006 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-05 | Oliveto Joseph Director · Officer: President and CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 679,000 | 0 | — | 679,000 | Direct (D) | No | F1, F2
| Open filing 0001437782-26-000007 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-05 | Hasija Amit Officer: CFO EVP of Corp. Development | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 204,000 | 0 | — | 204,000 | Direct (D) | No | F1, F2
| Open filing 0001787700-26-000005 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-04 | Muller Lorenz Officer: Chief Commercial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 204,000 | 0 | — | 204,000 | Direct (D) | No | F1
| Open filing 0001771207-26-000004 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-04 | Muller Lorenz Officer: Chief Commercial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 136,000 | 0 | — | 136,000 | Direct (D) | No | F2, F3
| Open filing 0001771207-26-000004 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-04 | Bharucha David Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 204,000 | 0 | — | 204,000 | Direct (D) | No | F1
| Open filing 0001910985-26-000005 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-04 | Bharucha David Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 136,000 | 0 | — | 136,000 | Direct (D) | No | F2, F3
| Open filing 0001910985-26-000005 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-04 | Nelson Jeffrey Edward Officer: Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 204,000 | 0 | — | 204,000 | Direct (D) | No | F1
| Open filing 0001943112-26-000004 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-04 | Nelson Jeffrey Edward Officer: Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 136,000 | 0 | — | 136,000 | Direct (D) | No | F2, F3
| Open filing 0001943112-26-000004 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-04 | Hasija Amit Officer: CFO EVP of Corp. Development | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 204,000 | 0 | — | 204,000 | Direct (D) | No | F1
| Open filing 0001787700-26-000004 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-04 | Hasija Amit Officer: CFO EVP of Corp. Development | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 136,000 | 0 | — | 136,000 | Direct (D) | No | F2, F3
| Open filing 0001787700-26-000004 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-04 | Oliveto Joseph Director · Officer: President and CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 679,000 | 0 | — | 679,000 | Direct (D) | No | F1
| Open filing 0001437782-26-000006 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-04 | Oliveto Joseph Director · Officer: President and CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 453,000 | 0 | — | 453,000 | Direct (D) | No | F2, F3
| Open filing 0001437782-26-000006 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-28 | Muller Lorenz Officer: Chief Commercial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 20,100 | — | — | 216,586 | Direct (D) | No | F5
| Open filing 0001771207-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-28 | Muller Lorenz Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 11,180 | 1.93 | 21,577.4Derived: shares × price per share. Exact value 21577.40. | 205,406 | Direct (D) | No | F3, F4
| Open filing 0001771207-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-28 | Muller Lorenz Officer: Chief Commercial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 20,100 | 0 | — | 60,300 | Direct (D) | No | F5, F7
| Open filing 0001771207-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-28 | Oliveto Joseph Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 66,600 | — | — | 517,267 | Direct (D) | No | F5
| Open filing 0001437782-26-000004 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-28 | Oliveto Joseph Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 34,523 | 1.93 | 66,629.39Derived: shares × price per share. Exact value 66629.39. | 482,744 | Direct (D) | No | F3, F4
| Open filing 0001437782-26-000004 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-28 | Oliveto Joseph Director · Officer: President and CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 66,600 | 0 | — | 199,800 | Direct (D) | No | F5, F7
| Open filing 0001437782-26-000004 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-28 | Hasija Amit Officer: CFO EVP of Corp. Development | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 20,100 | — | — | 112,093 | Direct (D) | No | F5
| Open filing 0001787700-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-28 | Hasija Amit Officer: CFO EVP of Corp. Development | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 12,245 | 1.93 | 23,632.85Derived: shares × price per share. Exact value 23632.85. | 99,848 | Direct (D) | No | F3, F4
| Open filing 0001787700-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-28 | Hasija Amit Officer: CFO EVP of Corp. Development | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 20,100 | 0 | — | 60,300 | Direct (D) | No | F5, F7
| Open filing 0001787700-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-28 | Bharucha David Officer: Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 20,100 | — | — | 125,426 | Direct (D) | No | F5
| Open filing 0001910985-26-000003 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-28 | Bharucha David Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 12,245 | 1.93 | 23,632.85Derived: shares × price per share. Exact value 23632.85. | 113,181 | Direct (D) | No | F3, F4
| Open filing 0001910985-26-000003 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-28 | Bharucha David Officer: Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 20,100 | 0 | — | 60,300 | Direct (D) | No | F5, F7
| Open filing 0001910985-26-000003 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-28 | Nelson Jeffrey Edward Officer: Chief Operating Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 20,100 | — | — | 62,093 | Direct (D) | No | F5
| Open filing 0001943112-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-28 | Nelson Jeffrey Edward Officer: Chief Operating Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 12,245 | 1.93 | 23,632.85Derived: shares × price per share. Exact value 23632.85. | 49,848 | Direct (D) | No | F3, F4
| Open filing 0001943112-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-28 | Nelson Jeffrey Edward Officer: Chief Operating Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 20,100 | 0 | — | 60,300 | Direct (D) | No | F5, F7
| Open filing 0001943112-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-08 Filed 2026-01-09 | Oliveto Joseph Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 43,000 | 2.25 | 96,750Derived: shares × price per share. Exact value 96750.00. | 303,721 | Direct (D) | Yes | F1, F2
| Open filing 0001437782-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-07 Filed 2026-01-09 | Oliveto Joseph Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 500 | 2.25 | 1,125Derived: shares × price per share. Exact value 1125.00. | 346,721 | Direct (D) | Yes | F1
| Open filing 0001437782-26-000002 Read from the filing’s XML Dispute this row |
| 2025-12-15 Filed 2026-01-28 | Muller Lorenz Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 53,566 | 2.32 | 124,273.12Derived: shares × price per share. Exact value 124273.12. | 196,486 | Direct (D) | No | F3, F4
| Open filing 0001771207-26-000002 Read from the filing’s XML Dispute this row |
| 2025-12-15 Filed 2026-01-28 | Oliveto Joseph Director · Officer: President and CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 133,054 | 2.32 | 308,685.28Derived: shares × price per share. Exact value 308685.28. | 450,667 | Direct (D) | No | F3, F4
| Open filing 0001437782-26-000004 Read from the filing’s XML Dispute this row |
| 2025-12-15 Filed 2026-01-28 | Hasija Amit Officer: CFO EVP of Corp. Development | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 58,007 | 2.32 | 134,576.24Derived: shares × price per share. Exact value 134576.24. | 91,993 | Direct (D) | No | F3, F4
| Open filing 0001787700-26-000002 Read from the filing’s XML Dispute this row |
| 2025-12-15 Filed 2026-01-28 | Bharucha David Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 58,007 | 2.32 | 134,576.24Derived: shares × price per share. Exact value 134576.24. | 105,326 | Direct (D) | No | F3, F4
| Open filing 0001910985-26-000003 Read from the filing’s XML Dispute this row |
| 2025-12-15 Filed 2026-01-28 | Nelson Jeffrey Edward Officer: Chief Operating Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 58,007 | 2.32 | 134,576.24Derived: shares × price per share. Exact value 134576.24. | 41,993 | Direct (D) | No | F3, F4
| Open filing 0001943112-26-000002 Read from the filing’s XML Dispute this row |
| 2025-12-12 Filed 2026-01-28 | Muller Lorenz Officer: Chief Commercial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 100,000 | — | — | 250,052 | Direct (D) | No | F1, F2
| Open filing 0001771207-26-000002 Read from the filing’s XML Dispute this row |
| 2025-12-12 Filed 2026-01-28 | Muller Lorenz Officer: Chief Commercial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 100,000 | 0 | — | 100,000 | Direct (D) | No | F6
| Open filing 0001771207-26-000002 Read from the filing’s XML Dispute this row |
| 2025-12-12 Filed 2026-01-28 | Oliveto Joseph Director · Officer: President and CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 280,000 | — | — | 583,721 | Direct (D) | No | F1, F2
| Open filing 0001437782-26-000004 Read from the filing’s XML Dispute this row |
| 2025-12-12 Filed 2026-01-28 | Oliveto Joseph Director · Officer: President and CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 280,000 | 0 | — | 280,000 | Direct (D) | No | F6
| Open filing 0001437782-26-000004 Read from the filing’s XML Dispute this row |
| 2025-12-12 Filed 2026-01-28 | Hasija Amit Officer: CFO EVP of Corp. Development | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 100,000 | — | — | 150,000 | Direct (D) | No | F1, F2
| Open filing 0001787700-26-000002 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.
Showing 1–50 of 86
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| Propel Bio Management, LLC Partly reported under another manager | 9,449,727 SH | 8,180,629 dollars | Higher by 2,020,137 Prior quarter: 7,429,590 | Open filing 0001829126-26-012373 Filed 2026-11-13 Dispute this row |
| Pavaki Capital Management LLC | 9,337,848 SH | 8,083,775 dollars | Higher by 270,000 Prior quarter: 9,067,848 | Open filing 0002143027-26-000014 Filed 2026-10-26 Dispute this row |
| RTW INVESTMENTS, LP | 7,833,336 SH | 6,781,319 dollars | Unchanged Prior quarter: 7,833,336 | Open filing 0001493215-26-000214 Filed 2026-11-16 Dispute this row |
| Point72 Asset Management, L.P. | 5,467,247 SH | 4,732,996 dollars | Higher by 56,109 Prior quarter: 5,411,138 | Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row |
| Simplify Asset Management Inc. | 3,349,379 SH | 2,899,557 dollars | Unchanged Prior quarter: 3,349,379 | Open filing 0001172661-26-004722 Filed 2026-10-27 Dispute this row |
| MILLENNIUM MANAGEMENT LLC | 2,235,274 SH | 1,935,077 dollars | Lower by 906,945 Prior quarter: 3,142,219 | Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row |
| TWO SIGMA INVESTMENTS, LP | 1,721,021 SH | 1,489,888 dollars | Lower by 318,994 Prior quarter: 2,040,015 | Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row |
| Kalehua Capital Management LLC | 1,651,258 SH | 1,429,494 dollars | Lower by 887,216 Prior quarter: 2,538,474 | Open filing 0002106181-26-000010 Filed 2026-11-13 Dispute this row |
| RVW Wealth, LLC | 1,148,260 SH | 994,049 dollars | Not in the prior quarter’s filings read | Open filing 0001756543-26-000005 Filed 2026-10-06 Dispute this row |
| MARSHALL WACE, LLP Partly reported under another manager | 1,117,642 SH | 972,350 dollars | Lower by 680,053 Prior quarter: 1,797,695 | Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row |
| Lion Point Capital, LP | 820,000 SH | 709,874 dollars | Unchanged Prior quarter: 820,000 | Open filing 0001013594-26-001194 Filed 2026-11-16 Dispute this row |
| TORONTO DOMINION BANK | 750,000 SH | 649,275 dollars | Unchanged Prior quarter: 750,000 | Open filing 0002052595-26-000123 Filed 2026-11-16 Dispute this row |
| Boxer Capital Management, LLC | 666,666 SH | 577,132 dollars | Unchanged Prior quarter: 666,666 | Open filing 0001213900-26-120704 Filed 2026-11-16 Dispute this row |
| AMERIPRISE FINANCIAL INC Partly reported under another manager | 666,666 SH | 577,133 dollars | Unchanged Prior quarter: 666,666 | Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 617,847 SH | 534,870 dollars | Lower by 17,364 Prior quarter: 635,211 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| UBS Group AG Partly reported under another manager | 465,239 SH | 402,897 dollars | Lower by 164 Prior quarter: 465,403 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| Aptus Capital Advisors, LLC | 405,000 SH | 350,609 dollars | Higher by 65,550 Prior quarter: 339,450 | Open filing 0001398344-26-020003 Filed 2026-11-13 Dispute this row |
| GUARDIAN WEALTH ADVISORS, LLC / NC | 405,000 SH | 350,609 dollars | Higher by 65,550 Prior quarter: 339,450 | Open filing 0001398344-26-020133 Filed 2026-11-16 Dispute this row |
| LUMINUS MANAGEMENT LLC | 275,000 SH | 238,068 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-128425 Filed 2026-11-16 Dispute this row |
| LPL Financial LLC | 274,634 SH | 237,751 dollars | Higher by 53,761 Prior quarter: 220,873 | Open filing 0001403438-26-000005 Filed 2026-11-06 Dispute this row |
| JANE STREET GROUP, LLC Option: Call Partly reported under another manager | 213,100 SH | 184,481 dollars | Higher by 197,100 Prior quarter: 16,000 | Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row |
| Wealthspire Advisors, LLC | 159,500 SH | 138,080 dollars | Higher by 18,871 Prior quarter: 140,629 | Open filing 0001646247-26-000006 Filed 2026-11-13 Dispute this row |
| Valeo Financial Advisors, LLC Partly reported under another manager | 146,699 SH | 126,997 dollars | Higher by 16,000 Prior quarter: 130,699 | Open filing 0001722641-26-000006 Filed 2026-10-08 Dispute this row |
| CITADEL ADVISORS LLC Option: Call Partly reported under another manager | 120,100 SH | 103,971 dollars | Higher by 64,000 Prior quarter: 56,100 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| Virtu Financial LLC Partly reported under another manager | 113,848 SH | 99 dollars | Higher by 102,235 Prior quarter: 11,613 | Open filing 0001533964-26-000015 Filed 2026-11-17 Dispute this row |
| SIMPLEX TRADING, LLC Option: Call | 113,000 SH | 97,824 dollars | Higher by 54,200 Prior quarter: 58,800 | Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row |
| BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager | 110,918 SH | 96,022 dollars | Lower by 62,786 Prior quarter: 173,704 | Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row |
| ADAR1 Capital Management, LLC | 100,000 SH | 86,570 dollars | Unchanged Prior quarter: 100,000 | Open filing 0001940272-26-000033 Filed 2026-11-16 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager | 98,864 SH | 85,587 dollars | Lower by 261,031 Prior quarter: 359,895 | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| Cascades Capital Asset Management, LLC | 83,610 SH | 104,513 dollars | Unchanged Prior quarter: 83,610 | Open filing 0001398344-26-020173 Filed 2026-11-16 Dispute this row |
| Pinnacle Wealth Planning Services, Inc. | 79,070 SH | 68,451 dollars | Not in the prior quarter’s filings read | Open filing 0001726752-26-000006 Filed 2026-10-27 Dispute this row |
| HRT FINANCIAL LP | 66,528 SH | 57 dollars | Not in the prior quarter’s filings read | Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row |
| XTX Topco Ltd Partly reported under another manager | 62,565 SH | 54,163 dollars | Higher by 36,248 Prior quarter: 26,317 | Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row |
| CITADEL ADVISORS LLC Option: Put Partly reported under another manager | 46,900 SH | 40,601 dollars | Lower by 117,400 Prior quarter: 164,300 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| Waterloo Capital, L.P. | 46,633 SH | 40,370 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-128557 Filed 2026-11-16 Dispute this row |
| October Effect Ltd | 40,000 SH | 34,628 dollars | Unchanged Prior quarter: 40,000 | Open filing 0002078353-26-000004 Filed 2026-10-20 Dispute this row |
| Focus Partners Wealth | 36,000 SH | 31,165 dollars | Unchanged Prior quarter: 36,000 | Open filing 0001542153-26-000021 Filed 2026-11-12 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 34,375 SH | 29,758 dollars | Higher by 1,488 Prior quarter: 32,887 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Put Partly reported under another manager | 32,400 SH | 28,188 dollars | Higher by 9,800 Prior quarter: 22,600 | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| Mariner, LLC | 27,830 SH | 24,092 dollars | Unchanged Prior quarter: 27,830 | Open filing 0001580642-26-007648 Filed 2026-11-12 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 27,238 SH | 23,580 dollars | Higher by 4,674 Prior quarter: 22,564 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| IMC-Chicago, LLC Option: Call | 27,100 SH | 23,460 dollars | Higher by 3,900 Prior quarter: 23,200 | Open filing 0001452861-26-000007 Filed 2026-11-05 Dispute this row |
| Federation des caisses Desjardins du Quebec Partly reported under another manager | 26,805 SH | 23,209 dollars | Lower by 2,976 Prior quarter: 29,781 | Open filing 0002022297-26-000010 Filed 2026-11-16 Dispute this row |
| RAYMOND JAMES FINANCIAL INC Partly reported under another manager | 26,600 SH | 23,028 dollars | Lower by 3,470 Prior quarter: 30,070 | Open filing 0000720005-26-000081 Filed 2026-11-12 Dispute this row |
| GSA CAPITAL PARTNERS LLP | 25,468 SH | 22 dollars | Not in the prior quarter’s filings read | Open filing 0001362033-26-000013 Filed 2026-11-16 Dispute this row |
| Welch Forbes LLC | 25,000 SH | 21,643 dollars | Unchanged Prior quarter: 25,000 | Open filing 0000105495-26-000005 Filed 2026-11-04 Dispute this row |
| JANE STREET GROUP, LLC Option: Put Partly reported under another manager | 24,300 SH | 21,037 dollars | Lower by 6,900 Prior quarter: 31,200 | Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row |
| NATIONAL BANK OF CANADA /FI/ Partly reported under another manager | 23,500 SH | 20,210 dollars | Unchanged Prior quarter: 23,500 | Open filing 0000926171-26-000014 Filed 2026-11-16 Dispute this row |
| Exit Wealth Advisors, LLC. Partly reported under another manager | 22,692 SH | 19,644 dollars | Unchanged Prior quarter: 22,692 | Open filing 0001765380-26-000494 Filed 2026-11-13 Dispute this row |
| Taylor Financial Group, Inc. | 20,000 SH | 17,314 dollars | Unchanged Prior quarter: 20,000 | Open filing 0001172661-26-004800 Filed 2026-11-02 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- BOOTHBAY FUND MANAGEMENT, LLC 462,669 SH
- Seven Fleet Capital Management LP 270,233 SH
- Squarepoint Ops LLC 231,824 SH
- Balyasny Asset Management L.P. 220,498 SH
- TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC 150,000 SH
- Quadrature Capital Ltd 64,661 SH
- Bay Rivers Group 46,633 SH
- SG Americas Securities, LLC 45,574 SH
- GEODE CAPITAL MANAGEMENT, LLC 40,789 SH
- Tower Research Capital LLC (TRC) 24,185 SH
- HighTower Advisors, LLC 20,000 SH
- TWO SIGMA SECURITIES, LLC 16,745 SH
- WINTON GROUP Ltd 14,300 SH
- Safeguard Investment Advisory Group, LLC 12,406 SH
- Eaton Financial Holdings Company, LLC 10,250 SH
- Aptus Capital Advisors, LLC 500 SH
- Medallion Wealth Advisors, LLC 340 SH
- GROUP ONE TRADING LLC 224 SH
- MERCER GLOBAL ADVISORS INC /ADV 123 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| RTW Investments, LP Common Shares, no par value per share | 9.9 | 12,356,953.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 7 | Open filing 0001493215-26-000112 Dispute this row |
| Roderick Wong Common Shares, no par value per share | 9.9 | 12,356,953.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 7 | Open filing 0001493215-26-000112 Dispute this row |
| Adage Capital Management, L.P. Common Shares, no par value | 6.37 | 8,000,000.00 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-002920 Dispute this row |
| Robert Atchinson Common Shares, no par value | 6.37 | 8,000,000.00 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-002920 Dispute this row |
| Phillip Gross Common Shares, no par value | 6.37 | 8,000,000.00 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-002920 Dispute this row |
| Trails Edge Capital Partners, LP Common Shares | 4.3 | 5,333,333.00 | 03/20/2026 Filed 2026-03-26 | SCHEDULE 13G/AAmendment 2 | Open filing 0001493152-26-013007 Dispute this row |
| Trails Edge Biotechnology Master Fund, LP Common Shares | 4.3 | 5,333,333.00 | 03/20/2026 Filed 2026-03-26 | SCHEDULE 13G/AAmendment 2 | Open filing 0001493152-26-013007 Dispute this row |
| Ortav Yehudai Common Shares | 4.3 | 5,333,333.00 | 03/20/2026 Filed 2026-03-26 | SCHEDULE 13G/AAmendment 2 | Open filing 0001493152-26-013007 Dispute this row |
| Pavaki Capital Management LLC Common Shares, no par value | 7.3 | 9,067,848.00 | 12/31/2025 Filed 2026-08-07 | SCHEDULE 13G | Open filing 0002143027-26-000012 Dispute this row |
| Pavaki Capital Partners, LP Common Shares, no par value | 7.3 | 9,067,848.00 | 12/31/2025 Filed 2026-08-07 | SCHEDULE 13G | Open filing 0002143027-26-000012 Dispute this row |
| Ashok Rambhai Patel Common Shares, no par value | 7.3 | 9,067,848.00 | 12/31/2025 Filed 2026-08-07 | SCHEDULE 13G | Open filing 0002143027-26-000012 Dispute this row |
| RTW Investments, LP Common Shares, no par value per share | 9.9 | 9,155,168.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 6 | Open filing 0001493215-25-000045 Dispute this row |
| Roderick Wong Common Shares, no par value per share | 9.9 | 9,155,168.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 6 | Open filing 0001493215-25-000045 Dispute this row |
| Trails Edge Capital Partners, LP Common Shares | 9.9 | 9,017,880.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-25-023424 Dispute this row |
| Trails Edge Biotechnology Master Fund, LP Common Shares | 9.9 | 9,017,880.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-25-023424 Dispute this row |
| Ortav Yehudai Common Shares | 9.9 | 9,017,880.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-25-023424 Dispute this row |
| Adage Capital Management, L.P. Common Shares, no par value | 9.99 | 8,659,064.00 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G | Open filing 0000902664-25-004894 Dispute this row |
| Robert Atchinson Common Shares, no par value | 9.99 | 8,659,064.00 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G | Open filing 0000902664-25-004894 Dispute this row |
| Phillip Gross Common Shares, no par value | 9.99 | 8,659,064.00 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G | Open filing 0000902664-25-004894 Dispute this row |
| Trails Edge Capital Partners, LP Common Shares | 9.9 | 8,847,882.00 | 07/14/2025 Filed 2025-07-21 | SCHEDULE 13G | Open filing 0001641172-25-020404 Dispute this row |
| Trails Edge Biotechnology Master Fund, LP Common Shares | 9.9 | 8,847,882.00 | 07/14/2025 Filed 2025-07-21 | SCHEDULE 13G | Open filing 0001641172-25-020404 Dispute this row |
| Ortav Yehudai Common Shares | 9.9 | 8,847,882.00 | 07/14/2025 Filed 2025-07-21 | SCHEDULE 13G | Open filing 0001641172-25-020404 Dispute this row |
| Propel Bio Management, LLC Common Stock | 9.9 | 8,861,186.00 | 07/11/2025 Filed 2025-12-23 | SCHEDULE 13G | Open filing 0001969764-25-000003 Dispute this row |
| Leen Kawas Common Stock | 9.9 | 8,861,186.00 | 07/11/2025 Filed 2025-12-23 | SCHEDULE 13G | Open filing 0001969764-25-000003 Dispute this row |
| Richard Kayne Common Stock | 9.9 | 8,861,186.00 | 07/11/2025 Filed 2025-12-23 | SCHEDULE 13G | Open filing 0001969764-25-000003 Dispute this row |
| Propel Bio Partners LLC Common Stock | 9.9 | 8,861,186.00 | 07/11/2025 Filed 2025-12-23 | SCHEDULE 13G | Open filing 0001969764-25-000003 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,649,595 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 66,682 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,123 |
Filings made before the SEC required XML are listed, not extracted.